Rome.
The Cuban vaccine “sovereign 02“It will be the week that in its last phase, in which its effectiveness and safety will be evaluated, before it begins to be administered en masse to the population, said today an Italian researcher working on the project with the ‘Institute of Finlay vaccines from Cuba.
The drug, of which 100 million doses are to be produced by the country’s public pharmaceutical company Biocubafarma, will quickly overcome this phase, he said without specifying how long the latter process will take during an informal meeting with members of the Press Association Foreigner in Italy.
“Sovereign 02” is one of the 04:00 vaccinations than Cuba is developing with the aim of immunizing as soon as possible a country that has successfully controlled the disease, as the total number of deaths recorded since the pandemic was triggered does not exceed 304, the researcher explained.
He added that this is a 100% public vaccine, which is being developed for non-profit and has been developed rapidly thanks to the “excellent” network of researchers, epidemiologists and doctors that Cuba has.
This vaccine is very safe and will probably reach other places, as there are many countries interested in it, yet Cuba will vaccinate its citizens first, the Italian researcher explained.
The development of “sovereign 02“It has had the help of‘ collaborators and researchers from other countries ’, but is funded and directed by Cuba, Which has a long track record in “scientific dissemination, experimentation and development of vaccines,” he stressed.
After passing the last phase, in which the results of its effectiveness and safety will be known, the population will be massively vaccinated. Cuban, Added.